Published by Coherent Market Insights
Posted on September 20, 2021
3 min readLast updated: February 5, 2026
The bioinformatics market is set to grow at a 20.5% CAGR, reaching $46,261.2 million by 2027, driven by new solutions and increased adoption due to COVID-19.
Bioinformatics Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Bioinformatics Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/4158
Bioinformatics covers a wide range of scientific areas involving genomics, microbial, and animal and plant sciences. It can be used to design and evaluate sequencing experiments, as well as developing bioinformatics software. Bioinformatics has opened up many new opportunities for researchers due to its focus on information science, specifically computer science. This area of science strives to bridge the gap between the biology and technologies, thus facilitating the meaningful exchange of information.
Market Dynamics
Launch of new bioinformatics solutions is expected to propel growth of the global bioinformatics market. For instance, in January 2021, Illumina launched Illumina Connected Analytics, an integrated bioinformatics solution that provides a comprehensive, private, cloud-based data platform. Moreover, integration of deep learning and bioinformatics is also expected enable in-depth study of glycan molecules for understanding infections, thereby aiding in growth of the market.
R&D of novel bioinformatics pipeline to identify viruses in host-associated or environmental samples is expected to offer lucrative growth opportunities for players in the global bioinformatics market. High prevalence of cardiovascular diseases is also expected to aid in growth of the market. For instance, according to the American Heart Association’s Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of cardiovascular disease in 2016.
Emergence of Covid-19 has led to increasing adoption of bioinformatics, thereby propelling growth of the global bioinformatics market. For instance, globally, as of 4:58pm CET, 8 February 2021, there have been 105,805,951 confirmed cases of COVID-19, including 2,312,278 deaths, as reported to the World Health Organization. Moreover, increasing funding in bioinformatics is also expected to aid in growth of the market, For instance, in August 2020, Addex Therapeutics, a clinical-stage pharmaceutical company, and the SIB Swiss Institute of Bioinformatics, were awarded a US$ 669 thousand Innosuisse grant to apply computational approaches developed by SIB to identify new therapeutic indications for ADX10061, a potent and selective dopamine D1 receptor antagonist.
Major players in the global bioinformatics market are focused on R&D to expand their product portfolio. For instance, in June 2020, Intomics announced that the company is a part of the newly funded translate project on personalized diabetes treatment.
Top Key Players Include In Bioinformatics Market: Active Motif, Inc., Illumina, Inc., Life Technologies, Affymetrix, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Qiagen, Knome, Inc., GE Healthcare, Geneva Bioinformatics SA, Quest Diagnostics, bitBiome, Inc., Intomics, Advanced BioInformatics GmbH, and Fios Genomics Ltd.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/4158
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post At CAGR of 20.5% Bioinformatics Market reach a value of US$ 46,261.2 Mn by 2027 appeared first on Gatorledger.
The article discusses the growth of the bioinformatics market, projected to reach $46,261.2 million by 2027.
The launch of new bioinformatics solutions and increased adoption due to COVID-19 are key drivers.
Key players include Illumina, Inc., Life Technologies, and Bio-Rad Laboratories, among others.
Explore more articles in the Research Reports category
